Wednesday, 19 June, 2024
HomePharmaceutical

Pharmaceutical

FDA inaction despite asthma drug link to suicide

It took the US Food & Drug Administration (FDA) 12 years after launching a safety review of the allergy-and-asthma drug Singulair before it required a black-box...

No causal link between suicidal thoughts and obesity meds – FDA

The US Food and Drug Administration (FDA) says its preliminary review of reports related to suicidal thoughts or actions in patients treated with glucagon-like...

Two studies find inappropriate use of aspirin

Some patients may still be taking aspirin inappropriately, according to the findings of two single-centre retrospective studies, presented at the recent American Society of...

Patients sue Spanish government over banned painkiller

A patients group representing several British victims has launched legal action against the Spanish Government over claims it failed to safeguard people against the...

How the state is working to reduce stockouts

Over the past 10 years, the National Health Department has rolled out a range of electronic surveillance systems to monitor medicine stocks throughout healthcare...

US study finds serious side effects from weight-loss drugs

Diabetes drugs now popular for their serendipitous by-product – weight loss – have also been linked to increased risk of gastrointestinal side effects, including...

Needle-free anaphylaxis drug thwarted by FDA

A US drug company – ARS Pharma – which had been hoping for FDA approval last week of its flagship product, a needle-free treatment...

J&J probed for high TB drug prices and patent law 'abuse'

Just weeks after Johnson & Johnson, among other pharmaceutical giants, was exposed for charging South Africa 15% more than what it charged the European...

FDA approves rare bone disorder drug

The US Food and Drug Administration has approved French drugmaker Ipsen’s drug for a rare bone disorder, making it the first treatment available to...

US drug approval policy could be harming patients worldwide

While the US Food & Drug Administration’s accelerated-approval process was designed to ease access to life-saving drugs, communication gaps could mean people are undergoing...

New blood cancer therapy from Pfizer approved

Accelerated approval has been granted to a new therapy from Pfizer for a specific type of blood cancer that is difficult to treat, said...

FDA approves first postpartum depression pill

The US Food and Drug Administration has approved Biogen and Sage Therapeutics’ postpartum depression pill (PPD), reports Reuters. The companies had also sought approval for the...

Priciest cancer drugs bumped off WHO’s medicines list

Several exorbitantly priced medicines, including some breast and lung cancer drugs, have been excluded from the updated Essentials Medicines List (EML) and Essential Medicines...

J&J patent deal allows for cheaper generic TB drugs, but SA may lose out

Johnson & Johnson has struck a deal to allow generic versions of its TB drug to be supplied to low-income countries – but critics...

Experts hail latest results for Alzheimer’s drug, despite side effects

Eli Lilly’s experimental drug donanemab slowed the progression of Alzheimer’s by 60% for patients in the earliest stages of the brain-wasting disease, according to...

Approval sought for two paediatric antibiotics for MDR infections

US pharmaceutical company Melinta Therapeutics is to receive funding from the government’s Biomedical Advanced Research and Development Authority (BARDA) to advance two antibiotics targeting...

Full FDA approval for Alzheimer’s drug

The first treatment targeting Alzheimer’s disease has been given full FDA approval, the agency announced last week, giving the green light to the anti-amyloid...

Infant RSV drug gets green light from FDA panel

AstraZeneca and Sanofi’s drug to prevent respiratory syncytial virus (RSV) has been given approval by a US regulatory panel, for use in infants, potentially...

Government shuns local vaccine-maker and switches to imports

While Ministers are punting South Africa as a biopharmaceutical investment destination and government has bemoaned the lack of vaccine manufacturing capacity in the country,...

COVID-vaccine market gets crowded as demand wanes and sales flatten

After the initial frenzy to produce effective global COVID-19 vaccines, sales have flattened and demand has contracted, writes STATNews. The target of vaccinating 70%...

Oops! So sorry about that, Zantac…

An influential study linking a popular heartburn drug to cancer has been retracted after the authors concluded that their finding was a testing error,...

NICE approves enzalutamide for advanced prostate cancer

The UK's National Institute for Health and Care Excellence (NICE) has recommended enzalutamide (Xtandi) as an option for treating advanced prostate cancer, writes MedicalBrief. Enzalutamide,...

FDA authorises Regeneron’s COVID-19 antibody treatment for injection

The US Food and Drug Administration has approved a lower dose of Regeneron’s coronavirus treatment for injection, reports Axios. The update to the company's emergency...

FDA's fiercely contested decision on new Alzheimer drug

The US Food & Drug Administration is under unparalleled pressure over its decision on novel Alzheimer's drug aducanumab, writes Medicalbrief. Advocacy groups, desperate for...

Insulin price illustrates global web of patent laws protecting Big Pharma

The high price of insulin, which has reached as much as $450 per month has raised outrage across the US, writes Faisal Chaudhry, professor...

Rwanda's cheap, generic morphine production model

By putting morphine production and distribution under government control a, Rwanda has become a model for Africa. As thousands die from addiction in rich countries...

Global study reveals relatively low cost of SA medicines

In a finding that may surprise many, South Africa ranked among the lowest on the cost of 13 common medicines in a 50-nation study by UK digital healthcare...

Unaffordable breast cancer medicines are killing SA women

Breast cancer remains the leading cancer affecting South Africa women. It is not only under-diagnosed but many will die needlessly because the most...

Health Compact 'waters down' access to affordable medicine

In May 2018, the Trade and Industry Department finally unveiled a new policy that would help to rein in pharmaceutical industry profiteering, but the...

Use of generics rises to a new high in SA's private sector

The use of cheaper generic alternatives rose to an all-time high of 62% in the private sector in 2018, while the top five chronic...

The high cost rare diseases: R54m for one-off injection

The Sunday Times reports on one SA family's journey with their daughter, who has spinal muscular atrophy, trying to access hugely expensive new breakthrough...

SA pharmacies 'knowingly stock dangerous and ineffective products'

The US Food and Drug Administration's Tainted Products Marketed as Dietary Supplements database lists hundreds of products with hidden active ingredients that are unsafe...

Running out of antibiotics under development — WHO report

A World Health Organisation (WHO) report shows a serious lack of antibiotics under development to combat the growing threat of antimicrobial resistance. Most of...

Health activists embrace IP policy draft, IPSA says it fuels misconceptions

Health activists have welcomed the SA Department of Trade and Industry’s latest draft intellectual property policy saying it contains important reforms that will make life-saving...

Amgen's cholesterol drug cuts cardiovascular risk – trial

Amgen said its cholesterol fighter Repatha significantly reduced the risk of heart attacks, strokes and death in patients with heart disease, according to initial...

Increases in drug prices puts pressure on European healthcare

Increases in cancer medicine prices in the UK, despite many medicines going off-patent, suggest that in many cases NHS price negotiations are failing to...

OECD: Many new drugs are bad value for money

An Organisation of Economic Co-operation and Development report has criticised the pricing strategy of the pharmaceutical industry, claiming that many new drugs are simply bad value for...

SA medicine price increase off to an early start

Aspen Pharmacare has welcomed both the 7.5% increase in the single exit price for medicines and scheduled substances announced by Health Minister Aaron Motsoaledi...

Treatment hope for ALCL patients

Stunning ‘before’ and ‘after’ scans of cancer patient Ian Brooks released by the Christie Hospital in Manchester, looked almost too good to be true,...